| 2020-09-11 |
TLC to Present at Cantor Virtual Global Healthcare Conference |
|
| 2020-09-09 |
TLC to Present at HC Wainwright & Co. 22nd Annual Global Investment Conference |
|
| 2020-09-03 |
TLC to Present at Baird’s 2020 Global Healthcare Conference |
|
| 2020-08-26 |
TLC and 3SBio Announce Acceptance of Marketing Authorization Application for Ampholipad™ in China |
|
| 2020-08-14 |
TLC Submits Investigational New Drug (IND) Application for TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19 |
|
| 2020-08-05 |
TLC Reports Second Quarter 2020 Financial Results and Provides Business Update |
|
| 2020-07-15 |
Manuscript Describes How TLC’s Inhalable Liposomal Hydroxychloroquine May Provide Clinical Benefit and Serve as Potential Treatment for COVID-19 |
|
| 2020-06-30 |
TLC Announces Completion of US$23 Million Financing |
|
| 2020-06-21 |
TLC Announces Scale-up Production Approval for Ampholipad™ |
|
| 2020-05-31 |
TLC Announces Topline Results for TLC590 Phase II Trial for Postsurgical Pain Management following Bunionectomy |
|
| 2020-05-18 |
TLC Highlights Findings in Abstract Accepted at Osteoarthritis Research Society International (OARSI) 2020 and Published in Osteoarthritis and Cartilage |
|
| 2020-05-13 |
TLC Reports First Quarter 2020 Financial Results and Provides Business Update |
|
| 2020-05-04 |
TLC Earns Highest Ranking in Corporate Governance Evaluation Six Years in a Row |
|
| 2020-02-12 |
TLC Announces Early Completion of Patient Enrollment in TLC590 Phase II Clinical Trial following Bunionectomy |
|
| 2020-02-11 |
TLC Reports Fiscal Year End 2019 Financial Results and Provides Business Update |
|
| 2020-01-08 |
TLC Announces Dosing of First Patients in Part 2 of TLC590 Phase II Trial for Postsurgical Pain following Bunionectomy |
|
| 2020-01-02 |
TLC to Present at 38th Annual JP Morgan Healthcare Conference |
|
